The Valley Desk

NCT05397600 · Interventional trial

Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

Overall registry status Completed

Phase 3

Conditions Glaucoma, Ocular Hypertension

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov